Not good, I bet this move sinks a lot of territories and then you will see the chinese fire drill if not at the end of this year then the beginning of next year when a ll the cash pay options are filtered out of numbers. There is no way Kowa will come even close to hitting the numbers that they want to without the cash option at $25. Check into cash pay for 30 days of 2 mg, it is around $160 average which means patients will pay $85, they can get generics for a lot less, this will not happen. There is one way for Kowa to hit the numbers and that is get more managed care wins- but this simply is not happening either. Good Luck!
